TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3322352

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Slow-release nifedipine (Adalat Retard)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Slow-release nifedipine (Adalat Retard) + Atenolol
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Nifedipine + Atenolol
Number of subjects: 18
Study: 31264787

Group type: EXPERIMENTAL
Intervention: Group cognitive behavioural therapy (GCBT)
Number of subjects: 88
Study: 30003994

Group type: EXPERIMENTAL
Intervention: 24 Gy in 2 SBRT fractions
Number of subjects: 145
Study: 27619827

Group type: EXPERIMENTAL
Intervention: 40 mg long-acting octreotide once every 4 weeks for 52 weeks
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: 40 mg long-acting octreotide
Number of subjects: 62
Study: 24987842

Group type: EXPERIMENTAL
Intervention: Method B (basket stretched out at the bottom of the stone)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Method A (basket inserted above the stone)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 65
Study: 22447019

Group type: EXPERIMENTAL
Intervention: Aspirin therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: No aspirin therapy
Number of subjects: 0
Study: 19910085

Group type: EXPERIMENTAL
Intervention: Continuous pump feeding (pump)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Intermittent bolus feeding (bolus)
Number of subjects: 178
Study: 18837074

Group type: EXPERIMENTAL
Intervention: Expertise-based design surgical technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional design surgical technique
Number of subjects: 0
Study: 16860521

Group type: EXPERIMENTAL
Intervention: Values clarification exercise (VCE) with summary
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Values clarification exercise (VCE) without summary
Number of subjects: 159

Group type: COMPARATOR
Intervention: Control group (no VCE)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Decision aid with the most helpful VCE
Number of subjects: 159

Group type: COMPARATOR
Intervention: Decision aid without the most helpful VCE
Number of subjects: 159
Study: 14578140

Group type: EXPERIMENTAL
Intervention: Multiple HPV types detected
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: CIN1 or CIN2 in tissues surrounding CIN3
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Extent of CIN1
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: ASC‐US/LSIL cell counts
Number of subjects: 133

Group type: COMPARATOR
Intervention: ASC‐H/HSIL cell counts
Number of subjects: 133
Study: 11130130

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Flexible Laryngeal Mask Airway (FLMA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intubating Laryngeal Mask (ILM)
Number of subjects: 30
Study: 8946970

Group type: EXPERIMENTAL
Intervention: Predictive model based on age > 55, iron deficiency, and weight loss
Number of subjects: 981

Group type: EXPERIMENTAL
Intervention: Age > 55, iron deficiency, weight loss
Number of subjects: 981
Study: 1463171

Group type: EXPERIMENTAL
Intervention: Prewarmed local anaesthetic solution (37 degrees C)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Room temperature local anaesthetic solution (25 degrees C)
Number of subjects: 44
Study: 6423162

Group type: EXPERIMENTAL
Intervention: Large volume, low pressure endotracheal tube cuffs (Portex Profile, Searle Sensiv, Mallinkrodt Hi‐Lo, Lanz)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cuff inflation pressure
Number of subjects: 40
Study: 30834686

Group type: EXPERIMENTAL
Intervention: Exposure indicators (EIs) collected from imaging departments
Number of subjects: 1422
Study: 29378255

Group type: EXPERIMENTAL
Intervention: Qscan device-based learning
Number of subjects: 100

Group type: COMPARATOR
Intervention: Traditional learning
Number of subjects: 100
Study: 26917956

Group type: EXPERIMENTAL
Intervention: Roflumilast in addition to ICS/LABA/LAMA
Number of subjects: 0
Study: 24500536

Group type: EXPERIMENTAL
Intervention: Intervention 2 (3‐h structured education program with personalized pedometer use)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Intervention 1 (3‐h group‐based structured education program aimed at promoting physical activity)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control (advice leaflet)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Intervention 2 compared to Control
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Increased physical activity at each time point
Number of subjects: 87
Study: 22927674

Group type: EXPERIMENTAL
Intervention: SafeCare home-based model
Number of subjects: 354
Study: 19282124

Group type: EXPERIMENTAL
Intervention: 200 mg lopinavir + 50 mg ritonavir tablet formulation
Number of subjects: 36
Study: 17975231

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (100 mg/kg i.v. bolus, 20 mg/kg/hr infusion until four hours after cardiopulmonary bypass)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 177
Study: 14561235

Group type: EXPERIMENTAL
Intervention: Intermittent hypobaric hypoxia (simulated altitude of 4500 m for 90 min, three times a week for 3 weeks)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (not exposed to intermittent hypoxia)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intermittent hypobaric hypoxia
Number of subjects: 12
Study: 11041902

Group type: EXPERIMENTAL
Intervention: Meloxicam 3.75 mg/d
Number of subjects: 774

Group type: EXPERIMENTAL
Intervention: Meloxicam 7.5 mg/d
Number of subjects: 774

Group type: EXPERIMENTAL
Intervention: Meloxicam 15 mg/d
Number of subjects: 774

Group type: EXPERIMENTAL
Intervention: Diclofenac 100 mg (50 mg twice daily)
Number of subjects: 774

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 774
Study: 8977598

Group type: EXPERIMENTAL
Intervention: Budesonide 800 micrograms twice daily plus terbutaline 1000 micrograms three times daily
Number of subjects: 16

Group type: COMPARATOR
Intervention: Budesonide 800 micrograms twice daily
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Budesonide plus terbutaline
Number of subjects: 16
Study: 1611833

Group type: EXPERIMENTAL
Intervention: Low glycaemic index diet
Number of subjects: 15
Study: 6487498

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Omeprazole 80 mg
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 30120640

Group type: EXPERIMENTAL
Intervention: BTX-A (200 units injected into the gastric antrum and body)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (0.9% saline injections)
Number of subjects: 32
Study: 27492428

Group type: EXPERIMENTAL
Intervention: Ambu
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: I-gel
Number of subjects: 105

Group type: COMPARATOR
Intervention: LMA-S
Number of subjects: 105
Study: 25771831

Group type: EXPERIMENTAL
Intervention: Lactose-free milk
Number of subjects: 40

Group type: COMPARATOR
Intervention: Regular infant formula (Control)
Number of subjects: 40
Study: 24756739

Group type: EXPERIMENTAL
Intervention: Mat Pilates programme (8 weeks, 3 times weekly)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (maintained normal daily activities)
Number of subjects: 50
Study: 20660010

Group type: EXPERIMENTAL
Intervention: Agomelatine 25 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Agomelatine 50 mg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 19323660

Group type: EXPERIMENTAL
Intervention: Androgenic alopecia group
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group (n=87)
Number of subjects: 97
Study: 17026493

Group type: EXPERIMENTAL
Intervention: Biphasic insulin aspart 30 (BIAsp30)
Number of subjects: 23
Study: 16750496

Group type: EXPERIMENTAL
Intervention: 50 Gy radiotherapy given in 25 fractions
Number of subjects: 1410

Group type: EXPERIMENTAL
Intervention: 39 Gy given in 13 fractions
Number of subjects: 1410

Group type: EXPERIMENTAL
Intervention: 42.9 Gy given in 13 fractions
Number of subjects: 1410
Study: 10673518

Group type: COMPARATOR
Intervention: Fludarabine (FLU) alone
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Fludarabine plus idarubicin (FLU-ID)
Number of subjects: 199
Study: 8640997

Group type: EXPERIMENTAL
Intervention: Diuretic therapy (hydrochlorothiazide plus amiloride)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo transdermal nitroglycerin
Number of subjects: 12
Study: 1639045

Group type: EXPERIMENTAL
Intervention: Glycogen depletion treatment (exercise + low-carbohydrate high-fat diet)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Glycogen repletion treatment (exercise + high carbohydrate diet)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Diet treatment (low-carbohydrate high-fat diet alone)
Number of subjects: 8
Study: 6440460

Group type: EXPERIMENTAL
Intervention: 100% glucose
Number of subjects: 27

Group type: COMPARATOR
Intervention: 50% fat 50% glucose
Number of subjects: 27
Study: 29143934

Group type: EXPERIMENTAL
Intervention: KAMUT® khorasan products
Number of subjects: 30
Study: 29784190

Group type: EXPERIMENTAL
Intervention: Robot-assisted laparoscopic radical cystectomy (RARC)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Open radical cystectomy (ORC)
Number of subjects: 118
Study: 26954669

Group type: EXPERIMENTAL
Intervention: Continuous supraclavicular block
Number of subjects: 75

Group type: COMPARATOR
Intervention: Continuous interscalene block
Number of subjects: 75
Study: 24327422

Group type: EXPERIMENTAL
Intervention: Surgical treatment for spinal metastasis post-RCT
Number of subjects: 7404
Study: 21904945

Group type: EXPERIMENTAL
Intervention: Health maintenance reminders via a secure PHR 'eJournal'
Number of subjects: 3979

Group type: COMPARATOR
Intervention: Active control arm with access to an eJournal for medications, allergies, and diabetes management
Number of subjects: 3979
Study: 19042044

Group type: EXPERIMENTAL
Intervention: 10 mg/d atorvastatin (statin group 1)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: 20 mg/d atorvastatin (statin group 2)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Control group (no atorvastatin)
Number of subjects: 119
Study: 18779613

Group type: EXPERIMENTAL
Intervention: Irinotecan plus carboplatin (IC)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Oral etoposide plus carboplatin (EC)
Number of subjects: 209
Study: 15925032

Group type: EXPERIMENTAL
Intervention: Intranasally administered Cholecystokinin (CCK)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 0
Study: 12872017

Group type: EXPERIMENTAL
Intervention: High-velocity resistance training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Low-velocity resistance training
Number of subjects: 30
Study: 10550374

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with three cycles of carboplatin/5-FU prior to surgery and radiotherapy (arm A)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Standard treatment with surgery and radiotherapy (arm B)
Number of subjects: 144
Study: 8908387

Group type: EXPERIMENTAL
Intervention: Intraperitoneal insulin injection (0.15 units/kg body wt)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Subcutaneous insulin injection (0.15 units/kg body wt)
Number of subjects: 8
Study: 1858956

Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 31190192

Group type: EXPERIMENTAL
Intervention: Intensive training program using sleep position trainer (SPT)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Gradual training program using sleep position trainer (SPT)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Both training modalities (intensive and gradual)
Number of subjects: 38
Study: 28207516

Group type: EXPERIMENTAL
Intervention: Weekly SMS interventions
Number of subjects: 2
Study: 26481293

Group type: EXPERIMENTAL
Intervention: Low-flux hemodialysis (LF-HD)
Number of subjects: 28

Group type: COMPARATOR
Intervention: High-flux hemodialysis (HF-HD)
Number of subjects: 28
Study: 23381211

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40mg/day (E40)
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: Esomeprazole 20mg/day (E20)
Number of subjects: 570

Group type: COMPARATOR
Intervention: Omeprazole 20mg/day (O20)
Number of subjects: 570
Study: 21074000

Group type: EXPERIMENTAL
Intervention: Acceptance-based coping
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control coping strategies
Number of subjects: 48
Study: 21129337

Group type: EXPERIMENTAL
Intervention: Low dose (5 g glucose, 0.5 U insulin)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Medium dose (10 g glucose, 1 U insulin)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: High dose (20 g glucose, 2 U insulin)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: All doses tested
Number of subjects: 16
Study: 17237317

Group type: EXPERIMENTAL
Intervention: Dietary and behavioral counseling to support adherence to trial dietary goals.
Number of subjects: 833
Study: 15522382

Group type: EXPERIMENTAL
Intervention: Frequency-doubling perimetry in patients with diabetes
Number of subjects: 50

Group type: COMPARATOR
Intervention: Frequency-doubling perimetry in nondiabetic normal controls
Number of subjects: 50
Study: 11856075

Group type: EXPERIMENTAL
Intervention: Budesonide enema (2 mg/100 mL at bedtime)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Oral metronidazole (0.5 g b.d.)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Budesonide enema
Number of subjects: 26

Group type: COMPARATOR
Intervention: Oral metronidazole
Number of subjects: 26
Study: 9642517

Group type: EXPERIMENTAL
Intervention: C2: 200-400 ng/ml
Number of subjects: 30

Group type: COMPARATOR
Intervention: C0: 100-200 ng/ml
Number of subjects: 30
Study: 8608684

Group type: EXPERIMENTAL
Intervention: Aceclofenac (100 mg twice daily)
Number of subjects: 397

Group type: COMPARATOR
Intervention: Diclofenac (50 mg three times daily)
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Aceclofenac
Number of subjects: 397

Group type: COMPARATOR
Intervention: Diclofenac
Number of subjects: 397
Study: 2681495

Group type: EXPERIMENTAL
Intervention: Sodium meclofenamate (Meclomen) 100 mg, p.os, t.i.d.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 956103

Group type: EXPERIMENTAL
Intervention: 250 mg ascorbic acid
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 500 mg ascorbic acid
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 31108557

Group type: EXPERIMENTAL
Intervention: Bidirectional barbed sutures (BBSs)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Traditional closure with Vicryl (V-group)
Number of subjects: 85
Study: 30532984

Group type: COMPARATOR
Intervention: 40 Gy whole-breast radiotherapy (control)
Number of subjects: 1265

Group type: EXPERIMENTAL
Intervention: 36 Gy whole-breast and 40 Gy partial-breast radiotherapy (reduced-dose)
Number of subjects: 1265

Group type: EXPERIMENTAL
Intervention: 40 Gy partial-breast radiotherapy only (partial-breast)
Number of subjects: 1265

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 1265
Study: 28398471

Group type: EXPERIMENTAL
Intervention: Higher amounts of joule energy and treatment planes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control treatment with lower joule energy and treatment planes
Number of subjects: 0
Study: 25757188

Group type: EXPERIMENTAL
Intervention: Budesonide/Formoterol Easyhaler
Number of subjects: 4
Study: 23933006

Group type: EXPERIMENTAL
Intervention: Low-tar cigarette
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: High-tar cigarette
Number of subjects: 16

Group type: COMPARATOR
Intervention: Both low-tar and high-tar cigarettes
Number of subjects: 16
Study: 20888091

Group type: EXPERIMENTAL
Intervention: Iron (100 mg/day as ferrous sulphate) and folic acid (500 μg/day) supplementation
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo (100 mg cane sugar)
Number of subjects: 117
Study: 19780802

Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 3 Hz rTMS
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 36
Study: 16413752

Group type: EXPERIMENTAL
Intervention: High-dose creatine supplementation (20 g/d for 1 week)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-dose creatine supplementation (5 g/d for 20 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study: 12562873

Group type: EXPERIMENTAL
Intervention: FHBL subjects
Number of subjects: 21

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 21
Study: 11142453

Group type: EXPERIMENTAL
Intervention: In-person intercessory prayer
Number of subjects: 40

Group type: COMPARATOR
Intervention: Supplemental, distant intercessory prayer
Number of subjects: 40
Study: 8967707

Group type: EXPERIMENTAL
Intervention: Cloxacillin alone (2 g intravenously every 4 hours for 14 days)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Cloxacillin plus gentamicin (1 mg/kg intravenously every 8 hours for 7 days)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Cloxacillin alone
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Cloxacillin plus gentamicin
Number of subjects: 90
Study: 7903135

Group type: EXPERIMENTAL
Intervention: Ivermectin 20 micrograms/kg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ivermectin 50 micrograms/kg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ivermectin 100 micrograms/kg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ivermectin 200 micrograms/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All dosages of ivermectin
Number of subjects: 60
Study: 3898930

Group type: EXPERIMENTAL
Intervention: Ceftriaxone (single intramuscular dose)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole (standard five-day regimen)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Number of subjects: 52

Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole
Number of subjects: 52
Study: 29949889

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight Collagen peptide (LMWCP) 1000 mg once daily for 12 weeks
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 27923369

Group type: EXPERIMENTAL
Intervention: Shu-Gan-Jian-Pi Decoction combined with prednisone and azathioprine
Number of subjects: 132

Group type: COMPARATOR
Intervention: Prednisone and azathioprine
Number of subjects: 132
Study: 24119887

Group type: EXPERIMENTAL
Intervention: Enhanced postoperative recovery pathways (Group 2)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Standard postoperative care (Group 1)
Number of subjects: 47
Study: 22694755

Group type: EXPERIMENTAL
Intervention: Steroid-free (SF) immunosuppression
Number of subjects: 130

Group type: COMPARATOR
Intervention: Steroid-based (SB) immunosuppression
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Steroid-free (SF) immunosuppression (subgroup under 5 years)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Steroid-based (SB) immunosuppression (subgroup under 5 years)
Number of subjects: 130
Study: 19962115

Group type: EXPERIMENTAL
Intervention: Group phone-based treatment
Number of subjects: 34

Group type: COMPARATOR
Intervention: Individual phone-based treatment
Number of subjects: 34
Study: 18555578

Group type: EXPERIMENTAL
Intervention: Rebaudioside A
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stevioside
Number of subjects: 0
Study: 15767846

Group type: EXPERIMENTAL
Intervention: Amantadine 200 mg
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 12068794

Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy
Number of subjects: 469

Group type: COMPARATOR
Intervention: Control group (no adjuvant radiotherapy)
Number of subjects: 469
Study: 10467921

Group type: EXPERIMENTAL
Intervention: Hypnotic suggestions to decrease pain affect (Experiment one)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hypnotic suggestions to increase and decrease pain affect (Experiment two)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hypnotic suggestions to modulate sensory aspect of pain (Experiment three)
Number of subjects: 0
Study: 8546501

Group type: EXPERIMENTAL
Intervention: Maternal HIV infection
Number of subjects: 476

Group type: EXPERIMENTAL
Intervention: Drug use during pregnancy
Number of subjects: 476

Group type: COMPARATOR
Intervention: Community controls
Number of subjects: 476
Study: 2141931

Group type: EXPERIMENTAL
Intervention: Thiocolchicoside
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study: 231914

Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg tubocurarine
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: 0.04 mg/kg pancuronium bromide
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control (sodium nitroprusside with tubocurarine)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control (sodium nitroprusside with pancuronium bromide)
Number of subjects: 76
Study: 31448737

Group type: EXPERIMENTAL
Intervention: General anaesthesia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Awake-regional anaesthesia
Number of subjects: 0
Study: 29241379

Group type: EXPERIMENTAL
Intervention: Fluoro‐edenite (FE) exposure
Number of subjects: 120

Group type: COMPARATOR
Intervention: Non-exposed subjects
Number of subjects: 120
Study: 26873050

Group type: EXPERIMENTAL
Intervention: Metronome-guided CPR at 120 compressions/min after training at 100 compressions/min
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Metronome-guided CPR at 120 compressions/min after training at 120 compressions/min
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Metronome-guided CPR at 120 compressions/min after training at 140 compressions/min
Number of subjects: 37
Study: 24605921

Group type: EXPERIMENTAL
Intervention: Sleep deprivation
Number of subjects: 96

Group type: COMPARATOR
Intervention: Well-rested condition
Number of subjects: 96
Study: 22679722

Group type: EXPERIMENTAL
Intervention: Chinese medical facial mask (twice a week for 4 weeks)
Number of subjects: 233

Group type: COMPARATOR
Intervention: 5% benzoyl peroxide gel (once in the evening for 4 weeks)
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Chinese medical facial mask
Number of subjects: 233

Group type: COMPARATOR
Intervention: 5% benzoyl peroxide gel
Number of subjects: 233